Hi Rich,
Very very interesting.
***Hi, Freddd.
***Thanks for the response.
After I wrote the post above, I began to wonder how your cells are able to make new DNA, because the thymidine needed must be made using 5,10 methylene THF, and with your SHMT enzyme shut down by high folinic acid, the 5,10 methylene THF would be low.
But then it hit me. You take a high dosage of methyl B12. This supplies a lot of methyl (1-carbon) groups. By taking high dosages of both methylfolate and methyl B12, you overdrive your methyation cycle. This causes the glycine N-methyl transferase reaction to kick in in order to drain off the excess methyl groups by converting glycine to sarcosine. The sarcosine is then used to convert THF to 5,10 methylene THF in lieu of the SHMT reaction, which is shut down by the high folinic acid. The result is that you are able to use methyl B12 to supply 1-carbon groups to form 5,10 methyene THF, and that gives you the substrate for making thymidine and hence DNA for making new cells. Very cool!
Making cells because of DNA transactions is a KEY indicator for me that I am not in folate deficiency. It stops at the drop of a hat and can start up again just as quickly. It's very binary, on-off, not graded.
***It sound like a very good indicator of intracellular folate availability in your case.
So with the glutathione induced folate deficiency the cell reproductiion shut down within hours, cheilitis burn in 8 hours and IBS two days after, and lots of symptoms that occur only after a sustained slower severe deficiency came on within days.
***I suggest that what happened here was that glutathione reacted with the methyl B12 to produce glutathionylcobalamin. It is reported in the literature that glutathione will react with other forms of B12, and that it is a rapid reaction. Normally, the B12 processing enzymes in the cells can utilize this to reform methylcobalamin. However, in your case, they do not seem to be able to do so, and I think there is a genomic cause for this. The details of this part of the B12 processing pathway have not yet been completely worked out by the researchers, so I can't identify a particular enzyme as being responsible, but I suspect that this pathway will be sorted out pretty soon. Anyway, this would shut down the availability of methyl B12 in your case, and since I'm suggesting that that is the source of the one-carbon groups to form 5,10-methylene THF, hence thymidine, and hence DNA in your case, it follows that your body's inability to make new cells would result from the shutdown in availability of methyl B12, and I think it is understandable that it could be sudden.
The folinic acid form took a couple of weeks to get to the cell reproduction shutdown
***O.K. It may have taken some time for the folinic acid to build up in the cells enough to inhibit the SHMT enzyme significantly.
and then IBS followed the cheilitis by 2 days, just as it does with folic acid or glutathione.
***O.K., that probably reflects the lifetime of the enterocytes. The old ones will serve a couple of days before being sloughed off. If there aren't enough new ones to replace them, the gut will start to have problems.
It just took longer for the folinic acid to build up to the initial shutdown point.
***O.K.
Then it lasted longer after I discontinued it.
***I think that would be consistent with not having high enough activity of the MTHFS enzyme, because it's the only one that can catalyze reactions with folinic acid. You may have a version that is present but very slow, so that eventually it does lower the folinic acid, but it takes time to do that.
If one looks at the diagram of these b12-folate reactions, if it is drawn assuming hydroxycbl or cyanocbl there is a different cycle than if it is drawn assuming mb12 in the first place.
***Normally, if just obtained orally, all the forms of cobalamin pass through the same sequence in the cells. The beta ligand is removed first, and then methyl B12 and adenosyl B12 are formed in the amounts needed by the cells. If larger dosages of methyl B12 are injected or taken sublingually, apparently it is able to diffuse into the cells and bypass the normal processing, based on your experience. I don't think the researchers have studied this process. It's somewhat surprising to me that a water-soluble molecule this large would be able to diffuse significantly through the lipid membranes, but apparently it does. Maybe it makes use of some of the pores or channels. I think this would be a very interesting thing to study, and it could have a lot of benefit, by placing your type of treatment on a sound scientific footing, which might make it more acceptable to the biomedical community, and thus enable it to help many more people.
There are a lot of alternative pathways in many of these things to get around missing items. Often the favored one is the least expensive in terms of energy or rare resources or preferred for some other reason.
***You're right. There is redundancy in the system that can often be exploited in cases where it is necessary to do so. I think the mechanism I suggested involving use of sarcosine to transfer methyl groups from methyl B12 in the methylation cycle over to form 5,10-methylene THF in the folate metabolism is one example of that.
I think all of this fits together pretty well. However, it doesn't explain your inability to make use of hydroxo B12 or your problems with glutathione and its precursors. To explain those features, I think I still have to invoke a mutation in the B12 intracellular processing enzymes, such as CblC. That would mean that there are two mutations, one in the B12 metabolism and one in the folate metabolism. These seems like a rare combination. I haven't found a MTHFS deficiency reported in the literature. It does seem that that is the situation though.
I think you are missing on the glutathione.
***Maybe so. Maybe it isn't a CblC mutation. As I noted above, it must be a problem with whatever enzyme normally removes glutathione from cobalamin so that it can be converted to methyl B12. This seems to be the step that isn't working properly. It has been published that a glutathione transferase reaction is normally used in the intracellular processing of B12, in the step that removes the methyl group from incoming methyl B12. So there must normally be a step that goes on to remove the glutathione, but this hasn't been specifically identified yet.
There was only one common factor tying all 10 who tried it together and all had a similar response, they were all successful on the active b12/Metafolin protocol. If they had not had success, they would be more likely to still have the deficiency symptoms glutathione causes in the first place and hence no change, no detrimental response. The side effects of cerefolin with NAC reflect the "NAC DETOX reaction" which are also folate deficiency symptoms which are reversed by Metafolin but they didn't recognize it since how could it be that when taking cerefolin. Metanx and Deplin don't have those side effects since they don't have NAC. These glutathione and NAC "detox" reactions are way too common to be some rare mutation.
***This is puzzling to me. As I understand what you are saying, these ten people had been on methylfolate and methyl B12 and had improved, and then they switched to CerefolinNAC and they went downhill with symptoms indicative of folate deficiency. Is that right? If so, then yes, it looks as though the added NAC is what caused these problems. Do you know what dosage of CerefolinNAC they used? Each caplet contains 600 mg of NAC.
***Here's the absract of a Russian paper that I just found on PubMed (note that vitamin B12b is hydroxocobalamin):
Tsitologiia. 2007;49(1):70-8.
[Prooxidant and cytotoxic action of N-acetylcysteine and glutathione combined with vitamin Bl2b].
[Article in Russian]
Solov'eva ME, Solov'ev VV, Faskhutdinova AA, Kudriavtsev AA, Akatov VS.
Abstract
We studied the prooxidant and cytotoxic action of thiols N-acetylcystein (NAC) and glutathione (GSH) combined with vitamin Bl2b. The synergism of action of the thiols and Bl2b resulted in human carcinoma cell damage was found. It was shown that GSH and NAC in physiological doses combined with Bl2b caused the initiation of apoptosis. It was established that prooxidant action of the thiols combined with vitamin Bl2b, i. e. generation and accumulation of hydrogen peroxide in culture medium, led to intracellular oxidative stress and injury of cell redox system. These effects were completely abolished by nonthiol antioxidants catalase and pyruvate. The chelators of iron phenanthroline and deferoxamine did not suppress the H2O2 accumulation in culture medium but significantly inhibited the cell death induced by the thiols combined with Bl2b. Therefore, the thiols GSH and NAC widely used as antioxidants, in combination with vitamin Bl2b show prooxidant characteristics and induce, with the participation of intracellular iron, apoptotic HEp-2 cell death.
PMID:
17432610
[PubMed - indexed for MEDLINE]
***Maybe this is the mechanism that caused the effects you have reported. The puzzling thing is that CerefolinNAC is used to treat preAlzheimer's patients, apparently beneficially, and it has also been rated fairly highly by PWCs on the CureTogether.com site, so it apparently is helpful to quite a few people. Perhaps it depends on the redox status of the people. If they are in severe oxidative stress, perhaps it causes problems, while if other antioxidants are present, as discussed in the Russian abstract, it does not cause problems, and is even helpful.
For the inability to utilize cyanocbl or hydroxcbl, they don't supply the methyl groups needed for the alternate pathway with the paradoxical folate deficiency.
***Oh, right! Thanks! I missed that! Yes, that now makes sense to me, too. As I've suggested, you are using methyl B12 to supply the 1-carbon groups that are needed in the folate metabolism to make DNA. The other forms of B12 would not supply these methyl groups. So that's another thing that would be consistent with MTHFS enzyme deficiency.
CblC is much more complete than my results which did not result in MCV> 100. It is rare to discover CblC in adults since the kids usually die if not treated as children. Hydroxcbl works for some and the rest die even if treated. I never had "failure to thrive" or anything like that. My body's failure with cyanocbl was partial.
***As I understand it from the recent literature, there are a large number of possible SNPs that can produce the CblC problem, and there is a range in severity, depending on which SNP is involved.
Of the group of other diseases that have low CSF cobalamin, MS is the one with the pattern of frequent remission and then worsening as those with paradoxical folate deficiency. It also is the one that has elevated CSF Hcy and normal CSF MMA
I do agree that there are some genetic factors present. There is the folate problem. There is some problem with dealing with inactive cobalamins but not the same problems as the Cbl X diseases. And finally I appear to have the same low CSF cobalamin as others with CFS/FMS. Each of my 3 children inherited various degrees of these 3 problems.